Evaluation of Liver Fibrosis With 2D-Shear Wave Elastography
NCT ID: NCT04759521
Last Updated: 2021-02-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
253 participants
OBSERVATIONAL
2019-01-03
2020-12-18
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
ShearWave™ Elastography to Assess Liver Fibrosis in Chinese Patients With Hepatitis B
NCT02313649
Liver Fibrosis Assessment With ShearWave Elastography
NCT02181452
S-Shearwave Elastography for Assessment of Hepatic Fibrosis
NCT03047707
Endosonographic Shear Wave Elastography for Liver Stiffness
NCT04533932
Assessment of Hepatic Fibrosis by Shear Wave Elastography in Patients With Liver Malignancy: A Prospective Single-center Study
NCT02958592
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group 1
Inactive HBsAg carriers were patients with HBsAg positivity for more than 6 months
No interventions assigned to this group
Group 2
Patients diagnosed with chronic hepatitis B were patients with HBsAg positivity for more than 6 months
No interventions assigned to this group
Group 3
The control group was composed of healthy individuals who were not infected with hepatitis B virus and did not fit any exclusion criteria.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. \> 18 years old
3. \< 64 years old
Exclusion Criteria
2. Have chronic or acute fulminant liver disease
3. Have DM disease
4. Hypertriglyceridemia, obesity, grade2 and higher hepatosteatosis,
5. Long-term drug use, alcohol intake that may damage the liver
6. Under the age of eighteen
7. Over sixty-five years old
8. Transplantation patients
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Seyhmus Kavak
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Seyhmus Kavak
MD, Radiologist
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sağlik Bilimleri Üniversitesi Training and Research Hospital
Diyarbakır, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2019/215
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.